Skip to content
Riskpilot
← Back to search
Sign in
Get full access
VBDK ApS
APS
Active
CVR 39670283
Kaffevej 39, 2610
Rødovre
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2018
— employees
Watchlist
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
VBDK ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
-42
75
30
-105
-136
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-42
75
30
-105
-136
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-42
75
30
-105
-136
Net financials
1
-1
-0
-0
0
Profit before tax
-41
74
30
-105
-136
Tax
-5
7
7
-0
-0
Net profit
-35
67
24
-105
-136
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
473
484
473
349
202
Equity
384
396
420
294
159
Long-term debt
0
0
0
0
0
Short-term debt
89
88
54
55
43
Total debt
89
88
54
55
43
Financial ratios
5-year trend
EBITDA margin
-13581100.0%
This company
15.8%
Market median
-85956429% vs market
2021
2025
Equity ratio
78.5%
This company
38.2%
Market median
+105% vs market
2021
2025
Return on equity
-85.4%
This company
18.4%
Market median
-564% vs market
2021
2025
Net profit margin
-13564900.0%
This company
8.1%
Market median
-167468001% vs market
2021
2025
Asset turnover
-0.67×
This company
1.12×
Market median
-160% vs market
2021
2025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on VBDK ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network